Literature DB >> 3322687

Dilated cardiomyopathy and myocarditis: natural history, etiology, clinical manifestations, and management.

S L Kopecky1, B J Gersh.   

Abstract

This monograph begins and ends with a statement of uncertainty regarding many aspects of dilated cardiomyopathy. Natural history studies identify patients with widely differing outcomes. A host of prognostic factors have emerged, yet it would appear that the major determinants of survival are as yet unrecognized. The diagnosis remains primarily one of exclusion, and management is largely nonspecific and supportive. The frequency of sudden cardiac death is well documented, but the ability to accurately identify patients at risk and the efficacy of antiarrhythmic therapy is unestablished. The emerging success of cardiac transplantation is a source of encouragement. The causes of dilated cardiomyopathy remain a source of intense investigation. Accumulating evidence (much of it circumstantial) does, however, implicate a viral etiology and perhaps altered function of the immunoregulatory system. However, the disparity between the severity of functional disturbance with the relative lack of histologic markers of cellular necrosis implies a disturbance at a cellular level. The etiology or etiologies remain elusive. Future investigation directed at fundamental aspects of cardiac cellular biology may provide the answers.

Entities:  

Mesh:

Year:  1987        PMID: 3322687     DOI: 10.1016/0146-2806(87)90002-8

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  7 in total

1.  Chronic respiratory illness as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S A Martin; S S Coughlin; C Metayer; A A René; I W Hammond
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

2.  What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; L Myers; R K Michaels
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

3.  Marital status as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC dilated cardiomyopathy study.

Authors:  C Metayer; S S Coughlin; E P McCarthy
Journal:  Eur J Epidemiol       Date:  1996-12       Impact factor: 8.082

4.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  From gene expression profiles to biological validation in enteroviral heart disease.

Authors:  Bobby Yanagawa; Bruce McManus; Zsuzsanna Hollander; Honglin Luo; Raymond Ng; Decheng Yang
Journal:  Exp Clin Cardiol       Date:  2003

6.  Infant cardiosphere-derived cells exhibit non-durable heart protection in dilated cardiomyopathy rats.

Authors:  Siyuan Wang; Weidan Chen; Li Ma; Minghui Zou; Wenyan Dong; Haili Yang; Lei Sun; Xinxin Chen; Jinzhu Duan
Journal:  Cytotechnology       Date:  2019-10-03       Impact factor: 2.058

7.  Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.

Authors:  Chenggang Mao; Xu Hou; Benzhen Wang; Jingwei Chi; Yanjie Jiang; Caining Zhang; Zipu Li
Journal:  Stem Cell Res Ther       Date:  2017-01-28       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.